Roche Acquires Good Therapeutics for US$250 M Upfront
By Lucy Haggerty
Pharma Deals Review: Vol 2022 Issue 9 (Table of Contents)
Published: 10 Sep-2022
DOI: 10.3833/pdr.v2022.i9.2720 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In an attempt to strengthen its cancer immunotherapy pipeline, Roche has entered into a definitive merger agreement to acquire Good Therapeutics for an upfront payment of US$250 M as well as further potential milestone payments...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS